Drug Profile
C 746
Alternative Names: C746Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Cosmederm Bioscience
- Class Anti-inflammatories; Antipruritics
- Mechanism of Action Cytokine inhibitors; Substance P inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Pain(In volunteers) in USA (Topical)
- 13 Oct 2014 Phase-I clinical trials in Pain (in volunteers) in USA (Topical)